SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing a sharp sell-off following the cancellation of purchase orders by Celestial AI, now owned by Marvell, which cited a breach of confidentiality obligations regarding shipping disclosures. The community is sharply divided, with bulls pointing to the company's solid underlying technology and cash position as reasons to buy the dip, while critics and short-sellers argue that management's communication failures and delayed disclosure have severely damaged institutional trust and long-term viability.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as it deepens its footprint in the AI infrastructure race through reports of a massive potential investment in Anthropic and the development of specialized TPU chips to challenge current hardware monopolies. Investors are closely tracking these developments alongside upcoming earnings, fueling community discussions around Alphabet's ability to maintain its AI dominance and cloud-segment growth.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science is experiencing high retail interest and significant volatility driven by its extremely low float and speculative social media buzz. Community members are actively debating the potential for a short squeeze, while others warn of the risks associated with the stock's history of dilution and weak financial performance.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is trending as investors debate the company's turnaround progress under leadership, fueled by recent earnings reports and strategic expansion efforts into home services and fintech assets. The community is actively divided between those who believe the revamped business model and leadership offer long-term value and skeptics concerned about historical performance, dilution, and the sustainability of the company's operational trajectory.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure and widespread investor frustration as the stock hits fresh lows, with many in the community debating whether the company is headed for bankruptcy, a reverse split, or a potential take-private deal. While some bulls remain focused on the potential of upcoming vehicle launches and backing from major strategic partners, bears continue to point to relentless dilution and significant cash burn as ongoing red flags.

Our vision is to create a global exchange using Ethereum blockchain, where everyone on this planet has the opportunity to buy and sell mobile bandwidth in any country just like you buy foreign currencies on FOREX.

DENT

DENT is currently driving heated debate across social platforms, with some users anticipating an explosive breakout and others dismissing it as a volatile asset. The community is actively tracking technical patterns and future potential, while keeping a close eye on broader market momentum.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as the community highlights the successful completion of the first point-to-point electric air taxi demonstration flights in New York City, marking a significant step toward real-world urban air mobility. Investors are actively discussing the stock's progress in FAA type certification and urban infrastructure integration, balancing excitement over these milestones against ongoing debates about cash burn and volatility in the eVTOL sector.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened community engagement as holders speculate on a potential recovery, fueled by ongoing token burn initiatives and persistent hopes for a supply shock. Discussions center on the coin's historical volatility and the collective determination of investors who view it as a high-risk, high-reward play despite its troubled past.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

Polyrizon is experiencing intense volatility and social media attention driven by recent clinical updates and news regarding a registered direct offering. Community members are actively debating the stock's potential for a short squeeze due to high borrow fees and thin float, while others express caution regarding dilution and the company's recent regulatory filings.

Dynatrace, Inc. engages in the advancing observability for today’s digital businesses, helping to transform the complexity of modern digital ecosystems into powerful business assets. By leveraging AI-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward. The company was founded by Bernd Greifeneder in 2005 and is headquartered in Boston, MA.

Dynatrace Inc

Dynatrace is seeing significant interest following reports that activist investor Starboard Value has taken a substantial stake in the company and is pushing management for margin improvements and accelerated capital returns. Community members are actively debating whether this activist pressure will successfully catalyze a stock re-rating or if broader sector rotation and AI-driven competition will continue to weigh on the company's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock...

Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average - Here's What Happened

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average - What's Next...

Adherex Technologies (NASDAQ:FENC) Given "Outperform" Rating at Wedbush

Wedbush reiterated an "outperform" rating and issued a $13.00 target price on shares of Adherex Technologies in a research note on Thursday...

Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average   - What's Next?

Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - Here's What Happened...

Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Adherex Technologies from a "buy" rating to a "hold" rating in a research note on Saturday...

Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares

Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,946 shares of Adherex Technologies stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $6.31, for a total value of $69,069.26. Following the completion of the transaction...

HC Wainwright Has Bearish Forecast for FENC Q1 Earnings

Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Adherex Technologies in a research note issued...

Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings

Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright lowered their Q1 2026 earnings estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC...

HC Wainwright Issues Negative Forecast for TSE:FRX Earnings

Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company...

HC Wainwright Issues Negative Forecast for FENC Earnings

Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Research analysts at HC Wainwright cut their Q3 2026 EPS estimates for shares of Adherex Technologies in a note issued to investors on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings pe...

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.04	--	--	N/A
Q4 '25	$0.04	-$0.17	-503.03%	MISSED
Q3 '25	-$0.02	-$0.02	9.09%	BEAT
Q2 '25	-$0.03	-$0.11	-223.53%	MISSED
Q1 '25	-$0.09	-$0.04	54.55%	BEAT

FENC
Fennec Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest FENC News

FENCFennec Pharmaceuticals Inc